Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Ho Joong Choi

Clin Mol Hepatol. 2022;28(1):117-119. Published online December 7, 2021

DOI: https://doi.org/10.3350/cmh.2021.0381

View: 6127 Download: 94 Web of Science: 9 Crossref: 9

Ho Joong Choi

Received June 4, 2024 Accepted June 6, 2024

DOI: https://doi.org/10.3350/cmh.2024.0426 [Epub ahead of print]

View: 481 Download: 25

Soon Kyu Lee, Ho Joong Choi, Young Kyoung You, Pil Soo Sung, Seung Kew Yoon, Jeong Won Jang, Jong Young Choi

Received June 14, 2024 Accepted September 29, 2024

DOI: https://doi.org/10.3350/cmh.2024.0451 [Accepted]

View: 242 Download: 61

Viewed By 4976	MAFLD: How is it different from NAFLD?
Viewed By 4840	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4761	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4476	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4433	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 214	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 155	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 133	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 117	MAFLD: How is it different from NAFLD?
Cited By 95	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Author :

Author index